{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:12:23Z","timestamp":1781619143975,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["AbbVie"],"award-info":[{"award-number":["AbbVie"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010721","name":"Ironwood Pharmaceuticals, Incorporated","doi-asserted-by":"publisher","award":["Ironwood Pharmaceuticals, Incorporated"],"award-info":[{"award-number":["Ironwood Pharmaceuticals, Incorporated"]}],"id":[{"id":"10.13039\/100010721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patient-reported outcomes (PROs) are required to assess the efficacy of treatments for functional constipation (FC), which is one of the most common functional gastrointestinal disorders in children. A novel PRO, the Pediatric Functional Constipation Symptom Diary (PFCSD), was developed to assess 7 core symptoms of FC (stool frequency, stool consistency, incomplete evacuation, straining, abdominal pain, abdominal bloating, and fecal incontinence) in pediatric FC patients. Here, we describe the psychometric analyses of the PFCSD using data from a phase 3 clinical trial of linaclotide (LIN-MD-64; NCT04026113) in children with FC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>This psychometric evaluation assessed the measurement properties (reliability, validity, responsiveness) and meaningful within-patient change thresholds for symptom scores derived from the PFCSD. Since spontaneous bowel movement (SBM) frequency and stool consistency (measured using the pediatric Bristol Stool Form Scale in the PFCSD) were key endpoints for the phase 3 clinical trial of linaclotide, scores from these 2 items were the primary focus of these psychometric analyses. Daily and weekly responses on the PFCSD were assessed across a 14-week period from 328 pediatric patients aged 6 to 17 years who met the modified Rome III criteria for child\/adolescent FC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Test-retest reliability, construct validity, and responsiveness of SBM frequency and stool consistency scores on the PFCSD were supported by this psychometric evaluation. Using intraclass correlation coefficients (ICCs), PFCSD scores on items measuring SBM frequency (ICC\u2009=\u20090.91) and stool consistency (ICC\u2009=\u20090.56) were consistent across repeated administrations. Convergent and discriminant correlations underscored the validity of SBM frequency and stool consistency scores on the PFCSD. The meaningful change threshold for weekly SBM frequency was identified as a change from baseline of \u2265\u20092 SBMs. For stool consistency, the meaningful change threshold ranged between +\u20090.8 to +\u20091.7 on the pediatric Bristol Stool Form Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The PFCSD is a novel, fit-for-purpose PRO measure evaluating key symptoms experienced by patients with FC aged 6 to 17 years. These analyses support the reliability, validity, and responsiveness of SBM frequency rate and stool consistency scores on the PFCSD in this target population and provide further guidance for interpreting meaningful changes in these scores at the individual level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-025-00945-7","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:19:45Z","timestamp":1763637585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychometric evaluation of a pediatric functional constipation symptom diary using randomized phase 3 clinical trial data"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2807-1715","authenticated-orcid":false,"given":"Julia","family":"Vishnevetsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"945_CR1","doi-asserted-by":"publisher","unstructured":"Leung AK, Hon KL (2021) Paediatrics: how to manage functional constipation. Drugs Context 10,2020-11-2 https:\/\/doi.org\/10.7573\/dic.2020-11-2","DOI":"10.7573\/dic.2020-11-2"},{"issue":"8","key":"945_CR2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3748\/wjg.v29.i8.1261","volume":"29","author":"DL Tran","year":"2023","unstructured":"Tran DL, Sintusek P (2023) Functional constipation in children: what physicians should know. World J Gastroenterol 29(8):1261\u20131288. https:\/\/doi.org\/10.3748\/wjg.v29.i8.1261","journal-title":"World J Gastroenterol"},{"key":"945_CR3","unstructured":"Carson RT, Abetz LN, Arbuckle RA et al (2010) Symptoms of pediatric chronic constipation: results of qualitative interviews with children and their primary caregivers. Presented at the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition 2010 Annual Scientific Meeting"},{"key":"945_CR4","unstructured":"Abetz L, Arbuckle R, Carson R et al (2010) Development of a pediatric chronic constipation symptom measures: results of qualitative interviews with children and their parents. Presented at the International Society for Quality of Life Research 2010 Annual Meeting"},{"issue":"9","key":"945_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2036.2010.04273.x","volume":"31","author":"J Belsey","year":"2010","unstructured":"Belsey J, Greenfield S, Candy D et al (2010) Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther 31(9):938\u2013949. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04273.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"945_CR6","doi-asserted-by":"publisher","first-page":"e0239092","DOI":"10.1371\/journal.pone.0239092","volume":"15","author":"S Rajindrajith","year":"2020","unstructured":"Rajindrajith S, Ranathunga N, Jayawickrama N et al (2020) Behavioral and emotional problems in adolescents with constipation and their association with quality of life. PLoS ONE 15(10):e0239092. https:\/\/doi.org\/10.1371\/journal.pone.0239092","journal-title":"PLoS ONE"},{"issue":"3","key":"945_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s2468-1253(23)00398-9","volume":"9","author":"C Di Lorenzo","year":"2024","unstructured":"Di Lorenzo C, Khlevner J, Rodriguez-Araujo G et al (2024) Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Gastroenterol Hepatol 9(3):238\u2013250. https:\/\/doi.org\/10.1016\/s2468-1253(23)00398-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"945_CR8","unstructured":"US Food and Drug Administration. FDA approves first treatment for pediatric functional constipation. June 12 (2023) Available at: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-pediatric-functional-constipation#:~:text=FDA%20has%20approved%20Linzess%20%28linaclotide%29%20capsules%20to%20treat,17%20years%20is%2072%20mcg%20orally%20once%20daily. Accessed: August 27, 2024"},{"issue":"2","key":"945_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"945_CR10","volume-title":"Psychometric theory","author":"JCBI Nunnally","year":"1994","unstructured":"Nunnally JCBI (1994) Psychometric theory. McGraw Hill, New York"},{"key":"945_CR11","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2 edn. Lawrence Erlbaum Associates, Hillsdale, New Jersey","edition":"2"},{"issue":"2","key":"945_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0021-9681(87)90069-5","volume":"40","author":"G Guyatt","year":"1987","unstructured":"Guyatt G, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40(2):171\u2013178. https:\/\/doi.org\/10.1016\/0021-9681(87)90069-5","journal-title":"J Chronic Dis"},{"issue":"5","key":"945_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.Mlr.0000062554.74615.4c","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41(5):582\u2013592. https:\/\/doi.org\/10.1097\/01.Mlr.0000062554.74615.4c","journal-title":"Med Care"},{"issue":"9","key":"945_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/s0895-4356(99)00071-2","volume":"52","author":"KW Wyrwich","year":"1999","unstructured":"Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52(9):861\u2013873. https:\/\/doi.org\/10.1016\/s0895-4356(99)00071-2","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"945_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","volume":"16","author":"LS Matza","year":"2013","unstructured":"Matza LS, Patrick DL, Riley AW et al (2013) Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health 16(4):461\u2013479. https:\/\/doi.org\/10.1016\/j.jval.2013.04.004","journal-title":"Value Health"},{"key":"945_CR16","doi-asserted-by":"publisher","first-page":"205566831989277","DOI":"10.1177\/2055668319892778","volume":"7","author":"B Byrom","year":"2020","unstructured":"Byrom B, Breedon P, Tulkki-Wilke R et al (2020) Meaningful change: defining the interpretability of changes in endpoints derived from interactive and mHealth technologies in healthcare and clinical research. J Rehabil Assist Technol Eng 7:2055668319892778. https:\/\/doi.org\/10.1177\/2055668319892778","journal-title":"J Rehabil Assist Technol Eng"}],"updated-by":[{"DOI":"10.1186\/s41687-026-01010-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000}}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00945-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00945-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:16:07Z","timestamp":1781615767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-025-00945-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00945-7","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article has been updated to correct the error in the author group","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s41687-026-01010-7","URL":"https:\/\/doi.org\/10.1186\/s41687-026-01010-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethics approval from a central institutional review board (Western-Copernicus Group Institutional Review Board, tracking number 20191616) and local institutional review boards of the participating centers when necessary. Participants performed written, informed consent prior to study participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JV, JLA, YX, and XY are employees of AbbVie and may hold shares and\/or stock options in the company. MA is an employee of Ironwood Pharmaceuticals and may hold Ironwood Pharmaceutical shares and\/or stock options. AbbVie and Ironwood sponsored the study; contributed to the design; participated in the collection, analysis, and interpretation of data; and participated in writing, reviewing, and approving the final version.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}